FI780073A - Foerfarande foer framstaellning av n2-arylsulfonyl-l-argininamider och dessas farmaceutiskt laempliga salter - Google Patents

Foerfarande foer framstaellning av n2-arylsulfonyl-l-argininamider och dessas farmaceutiskt laempliga salter

Info

Publication number
FI780073A
FI780073A FI780073A FI780073A FI780073A FI 780073 A FI780073 A FI 780073A FI 780073 A FI780073 A FI 780073A FI 780073 A FI780073 A FI 780073A FI 780073 A FI780073 A FI 780073A
Authority
FI
Finland
Prior art keywords
laempliga
dessas
argininamider
salter
pharmaceutical
Prior art date
Application number
FI780073A
Other languages
English (en)
Other versions
FI72316B (fi
FI72316C (fi
Inventor
Shosuke Okamoto
Ryoji Kikumoto
Yoshikuni Tamao
Kazuo Ohkubo
Tohro Tezuka
Shinji Tonomura
Akiko Hijikata
Original Assignee
Mitsupishi Chemical Ind Ltd
Shosuke Okamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/760,745 external-priority patent/US4066773A/en
Priority claimed from US05/760,672 external-priority patent/US4093712A/en
Priority claimed from US05/760,668 external-priority patent/US4073913A/en
Priority claimed from US05/760,676 external-priority patent/US4097472A/en
Priority claimed from US05/760,929 external-priority patent/US4101653A/en
Priority claimed from US05/776,195 external-priority patent/US4097591A/en
Priority claimed from JP6650877A external-priority patent/JPS6010028B2/ja
Priority claimed from US05/804,331 external-priority patent/US4140681A/en
Priority claimed from US05/804,368 external-priority patent/US4131673A/en
Application filed by Mitsupishi Chemical Ind Ltd, Shosuke Okamoto filed Critical Mitsupishi Chemical Ind Ltd
Publication of FI780073A publication Critical patent/FI780073A/fi
Priority to FI842539A priority Critical patent/FI74455C/fi
Publication of FI72316B publication Critical patent/FI72316B/fi
Publication of FI72316C publication Critical patent/FI72316C/fi
Application granted granted Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06Six-membered rings
    • C07D327/08[b,e]-condensed with two six-membered carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI780073A 1977-01-19 1978-01-10 Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och farmaceutiskt acceptabla salter daerav. FI72316C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI842539A FI74455C (fi) 1977-01-19 1984-06-21 Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och farmaceutiskt acceptabla salter daerav.

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US05/760,676 US4097472A (en) 1974-11-08 1977-01-19 N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
US05/760,668 US4073913A (en) 1974-11-08 1977-01-19 N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US05/760,929 US4101653A (en) 1974-11-08 1977-01-19 N2 -arylsulfonyl-argininamides and the pharmaceutically acceptable salts thereof
US05/760,745 US4066773A (en) 1974-11-08 1977-01-19 N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US76092977 1977-01-19
US76067677 1977-01-19
US76066877 1977-01-19
US05/760,672 US4093712A (en) 1974-11-08 1977-01-19 N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US76067277 1977-01-19
US76074577 1977-01-19
US05/776,195 US4097591A (en) 1974-11-08 1977-03-10 N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US77619577 1977-03-10
JP6650877A JPS6010028B2 (ja) 1977-06-06 1977-06-06 N↑2−アリ−ルスルホニル−l−アルギニンアミド類及び薬剤として許容され得るその塩
JP6650877 1977-06-06
US80433177 1977-06-07
US05/804,331 US4140681A (en) 1974-11-08 1977-06-07 N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US05/804,368 US4131673A (en) 1974-11-08 1977-06-07 N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US80436877 1977-06-07

Publications (3)

Publication Number Publication Date
FI780073A true FI780073A (fi) 1978-07-20
FI72316B FI72316B (fi) 1987-01-30
FI72316C FI72316C (fi) 1987-05-11

Family

ID=27577127

Family Applications (1)

Application Number Title Priority Date Filing Date
FI780073A FI72316C (fi) 1977-01-19 1978-01-10 Foerfarande foer framstaellning av farmaceutiskt aktiva n2-arylsulfonyl-l-argininamider och farmaceutiskt acceptabla salter daerav.

Country Status (17)

Country Link
CA (1) CA1131621A (fi)
CH (2) CH633773A5 (fi)
DD (1) DD137352A5 (fi)
DE (1) DE2801478A1 (fi)
DK (1) DK150521C (fi)
FI (1) FI72316C (fi)
GB (1) GB1596971A (fi)
GR (1) GR60787B (fi)
IL (1) IL53685A (fi)
IT (1) IT1126229B (fi)
NL (1) NL187746C (fi)
NO (1) NO158681C (fi)
NZ (1) NZ186198A (fi)
PH (1) PH15913A (fi)
SE (1) SE452624B (fi)
SU (1) SU1181539A3 (fi)
UA (1) UA8370A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794581B (en) * 1978-08-31 1981-04-29 Mitsubishi Chem Ind N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
GB9426038D0 (en) 1994-12-22 1995-02-22 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
FR2761065B1 (fr) * 1997-03-20 2000-03-03 Synthelabo Derives de n-(arginyle)benzenesulfonamide, leur preparation et leur application en therapeutique
CN111961114A (zh) * 2020-08-03 2020-11-20 扬州中宝药业股份有限公司 一种阿加曲班中间体及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978045A (en) * 1973-08-13 1976-08-31 Mitsubishi Chemical Industries Ltd. N2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof

Also Published As

Publication number Publication date
DK150521C (da) 1987-10-19
IL53685A (en) 1985-12-31
NO158681B (no) 1988-07-11
CH648293A5 (en) 1985-03-15
IT1126229B (it) 1986-05-14
NL187746C (nl) 1992-01-02
UA8370A1 (uk) 1996-03-29
CA1131621A (en) 1982-09-14
GB1596971A (en) 1981-09-03
IL53685A0 (en) 1978-03-10
DE2801478C2 (fi) 1991-01-31
NL7800448A (nl) 1978-07-21
NL187746B (nl) 1991-08-01
NZ186198A (en) 1980-12-19
NO780191L (no) 1978-07-20
SE452624B (sv) 1987-12-07
SU1181539A3 (ru) 1985-09-23
GR60787B (en) 1978-08-28
DE2801478A1 (de) 1978-07-20
CH633773A5 (en) 1982-12-31
SE7800512L (sv) 1978-07-20
DK150521B (da) 1987-03-16
DD137352A5 (de) 1979-08-29
FI72316B (fi) 1987-01-30
DK26378A (da) 1978-07-20
PH15913A (en) 1983-04-22
FI72316C (fi) 1987-05-11
NO158681C (no) 1988-10-19

Similar Documents

Publication Publication Date Title
NO143100C (no) Fremgangsmaate for fremstilling av belagt glass
FI780378A (fi) Anordning foer taendning och underblaosning av grill- och kamineld och liknande
IT1102018B (it) Procedimento per la produzione di trimetilol-alcani
IT1106615B (it) Procedimento per la produzione di solfobetaine
IT1109011B (it) Procedimento per la produzione di vincadifformina
IT1103464B (it) Procedimento per la produzione di derivati benzimidazolici
FI783198A (fi) Vaetskespridare foer en eldslaeckningsanordning
FI780496A (fi) Foerfarande och anordning foer utbredning av glasfiber
FI780565A (fi) Foerfarande foer framstaellning av d 1-5-metyltetrahydrofolsyra och salter daerav
FI781938A (fi) Foerfarande och anordning foer framstaellning av goerdeldaeckvaevnad
FI782434A (fi) Anordning foer smaeltning och raffinering av raokoppar
IT1105171B (it) Procedimento per la produzione di nitrosobenzolo
FI781357A (fi) Foerfarande och anordning foer framstaellning av polyuretanskum
FI780073A (fi) Foerfarande foer framstaellning av n2-arylsulfonyl-l-argininamider och dessas farmaceutiskt laempliga salter
IT1100590B (it) Procedimento per la produzione di rifamicine
FI782861A (fi) Foerfarande och anordning foer framstaellning av fiberskivmaterial
FI782574A (fi) Foerfarande foer framstaellning av n-substituerade 2-hydrazonopropionsyraderivat
SE7800239L (sv) Apparat for tillverkning av trekonstruktioner
IT1157730B (it) Procedimento per la produzione di alfa-idrossimetilen-nitrili
FI782220A (fi) Oxadiazol-1,2,4-derivat deras framstaellning och deras anvaendning i medicinvaord
IT7850920A0 (it) Procedimento per la produzione di pirazolantroni 3-sostituiti
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon
FI783898A (fi) Spectinomycinderivater deras salter med syror och foerfarande foer deras framstaellning
IT1099446B (it) Procedimento per la produzione di tiolcarbamati
IT1102812B (it) Procedimento per la produzione di p-nitroso-difenil-idrossil-ammine

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: MITSUBISHI KASEI CORPORATION

Owner name: OKAMOTO, SHOSUKE